Cryptosporidium parvum infectivity in a neonatal CD-1 mouse model was used to determine the dose needed to infect 50% of the population. The 50% infective dose was estimated to be 79 oocysts. It was observed that a mean oral inoculum of 23 oocysts produced infection in 2 of 25 neonatal mice 7 days postinoculation. All animals became infected when the mean oral dose exceeded 310 oocysts per animal. The dose response of C. parvum was modeled with a logit dose-response model suitable for use in water disinfection studies.
Cryptospondium parvum, an enteric parasite of vertebrates, was first reported to be a human pathogen in 1976 (19) . While immunocompetent adults clear the infection 3 to 4 weeks after exposure to oocysts, immunocompromised individuals are unable to eliminate the parasites from the small intestine and suffer from chronic cryptosporidiosis (23) . The recognition of C. parvum as a threat to immunocompromised individuals, such as AIDS patients, and the fact that the parasite was identified as the etiologic agent of several waterbome outbreaks of enteric illness have made the control of C. parvum a priority with public health officials and the water supply industry (5, 11). C. parvum has been reported to be resistant to many common disinfectants, including chlorine (3, 14). Currently, there is no effective chemotherapy available for treatment of cryptosporidiosis (16).
There is a need for an animal model for studying the infectivity of Cryptosporidium oocysts. There are applications for such a model in the water treatment industry and in pharmaceutical research because of the requirement for measuring the infection-blocking capability of water disinfection processes or the efficacy of an antimicrobial agent. The neonatal mouse host for C. parvum was developed after attempts to infect other immunocompetent rodents failed to produce symptomatic or reproducible infections (7). The 50% infective dose (ID50) in neonatal Swiss-Webster mice has been estimated to be between 100 and 500 oocysts (7). Others reported the ID50 to be 60 oocysts in neonatal BALB/c mice, although no data were provided (14). Little information is available on the infective dose of C. parvum in primates, although one study reported that inoculation with either 10 or 2 x 105 oocysts by means of a nasogastric tube resulted in clinical enteritis (17). The size of the inoculum had no apparent effect on the severity or duration of disease.
The purpose of this study was to develop the doseresponse characteristics for C. parvum in neonatal CD-1 mice. The objectives include determining the ID50 for this mouse strain and the minimum infectious dose. The data from this study can be used as a guide for researchers attempting to quantify the inactivation of C. parvum At the onset of scouring, the feces were collected in tap water and sequentially passed through 10-, 20-, 60-, 100-, 200-, and 400-mesh sieves (ATM Test Sieves, Inc., Milwaukee, Wis.) by agitating and washing the sieves with 0.01% (vol/vol) aqueous Tween 20. Concentration of the particulates from the sieved feces was by centrifugation at 1,100 x g for 10 min. Purification of the oocysts from the particulates was done on a step gradient of Sheather's sucrose (500 g of sucrose, 320 ml of distilled deionized water, 9 ml of phenol). In a 50-ml conical centrifuge tube, the equivalent of 1 ml of particulates was diluted to 25 ml with 0.01% Tween 20 and suspended by vortexing. The fecal slurry was underlaid with 15 ml of 1:4 Sheather's sucrose (200 ml of Sheather's sucrose, 800 ml of phosphate-buffered saline, 9 ml of Tween 80; specific gravity, 1.064). The 1:4 Sheather's sucrose band in turn was underlaid with 10 ml of 1:2 Sheather's sucrose (300 ml of Sheather's sucrose, 600 ml of phosphate-buffered saline, 9 ml of Tween 80; specific gravity, 1.103). The tube was spun in a swinging-bucket rotor at 1,100 x g for 20 min with gradual acceleration and deceleration and without braking. The interface between the two Sheather's sucrose bands was collected, diluted five times with 0.01% Tween 20, and centrifuged at 1,100 x g for 10 min. The resultant oocysts were washed two more times in 0.01% Tween 20 and centrifuged at 1,100 x g for 10 min. Normally, phase microscopic examination of the oocyst suspension at this point indicated that the suspension was still contaminated with fecal debris. Consequently, secondary and tertiary Sheather's step gradients were done until the C. parvum oocyst suspension was purified to near homogeneity. After the final wash step, the oocysts were suspended in 0.01% Tween 20 containing 100 U of penicillin, 100 ,g of streptomycin, and 100 p,g of gentamicin per ml and stored at 4°C. The oocyst concentration of the suspension was determined by counting 0.01% Tween 20 dilutions with a hemocytometer. The typical concentration of oocysts in the stock suspension was 1.5 x 108 to 2.5 x 108 per ml. The C. parvum oocysts were never exposed to 2.5% potassium dichromate as is commonly done (4).
Infectivity. The neonatal mouse model described by Ernest et al. (7) was used to evaluate the infectivity of C. parvum. Breeding pairs of CD-1 outbred mice were obtained from the Charles River Breeding Laboratories (St. Constant, Quebec, Canada). The animals were given food and water ad libitum and were housed in cages with covers fitted with a 0.22-p,m-pore-size filter in a specific-pathogen-free (P-2 level) animal facility.
Oocyst doses were prepared from the stock suspension of oocysts by serial dilution to obtain dosages between 18 and 400 oocysts per mouse. The oral dose given to the mice was determined from the mean of four hemocytometer counts of the stock suspension and the dilution factor. The dose was not corrected for in vitro excystation rates. The Fisher D2 statistic was used for quality control of the replicate counts (10). If the variance of the counts was within the amount expected from chance alone (P c 0.05), the mean count was used. Otherwise, the oocyst suspension was resampled and recounted.
The mice was inoculated orally 4 days after birth, using a pipette with known numbers of oocysts suspended in 5 to 10 pl of Milli-Q (Millipore Corp.) water. The infectivity of the oocysts was determined 7 days after infection. The mice were killed by cervical dislocation, and the lower half of the small intestine, the cecum, and the colon were removed and placed in 10 ml of Milli-Q water. The intestines were homogenized for 10 s in a Sorvall Omni-Mixer (Du Pont Co.) and washed three times in Milli-Q water containing 0.01% Tween 20 at 2,000 x g for 15 min. After centrifugation, the supernatant was discarded, 10 ml of Sheather's sugar solution was added to the pellet, and the solution was centrifuged at 1,000 x g for 10 min. A few drops from the surface of the suspension were removed and examined with differential interference contrast microscopy at x400. Mice were scored either positive or negative for oocysts after examination of the slide.
In vitro excystation was used as a quality control procedure to monitor changes in the oocyst preparation over the duration of the experiments. The in vitro excystation method of Woodmansee (24) (2, 8, 12, 13, 15) . However, it has been suggested that the log-normal model similar to the logit model used in this study gave similar results when compared with more sophisticated statistical models (12).
With equation 1, the ID50 (logit = 0) for oocysts in neonatal CD-1 mice was found to be 79 oocysts per animal.
At the minimum dose level used in this study (dose group 1), it was observed that 25 oocysts caused an infection in 2 of the 25 mice after 7 days. The two positive mice were from the same litter. In dose group 10, it was observed that 400 oocysts caused infection in 11 of 11 inoculated mice.
DISCUSSION
At the lowest mean dose of 23 oocysts per animal, infection was found in 2 of 25 animals. Interestingly, the two positive mice were both from the same litter. If one less litter had been used, it is quite possible that no animals would have been scored positive at the lowest inoculum. It is possible that the lowest dose level that was used in this study was near the threshold of the minimum infective dose for the neonatal mouse model. At a mean oral dose of 400 oocysts per animal, 100% of the animals responded with an infection. There was an apparent inconsistency in the dose response for data obtained for doses of 81 to 88 oocysts. No explanation of this anomaly could be found.
An earlier study used neonatal Swiss-Webster mice and examined three dose levels: 107 + 5 oocysts, 537 + 8 oocysts, and 1,096 + 10 oocysts per animal (7). There were 32 animals exposed at each dose level. The results of that study are summarized in Fig. 2 
